Post-legalization marijuana earnings continue to trickle in as Canadian cannabis firms release their earnings reports for the periods covering post October 17 recreational sales. Two of the early quarterly financial reports to give the market a better glimpse into the adult-use market dynamics were from Aphria (TSX:APHA)(NYSE:APHA) and most recently Organigram Holdings (TSXV:OGI).

If you're a fan of cannabis and a fan of kombucha, you'll be excited to hear that Calgary cannabis company, Zenabis has officially acquired a 51% stake in a True Buch, a Canadian kombucha company. In addition to this exciting news, the company has decided to release their own line of cannabis-infused kombucha drinks for Canadians to enjoy.

Kombucha and cannabis have been everywhere this year. Kombucha is a bubbly fermented beverage made out of tea elixir with Asian root and dates back nearly 2000 years. Filled with living probiotics, enzymes, and amino acids, this concoction is known by many to be the go-to healthy drink.

Two cannabis entrepreneurs who sold their first pot company to Canopy Growth Corp. for $430 million (US$324 million) may hit pay dirt again when they take their cannabis brand company public.

Slang Worldwide Inc., co-founded by Peter Miller and Billy Levy, begins trading at $1.50 a share Tuesday on the Canadian Securities Exchange for a market value of about $500 million, according to a company representative. That would be more valuable than Mettrum Health Corp. when Miller and Levy sold it in early 2017 to Canopy, the world’s largest cannabis company.

The head of Canopy Growth’s retail operation leaves company after less than six months on the job

News that the Israeli government had finally approved the export of cannabis products from the local growers stirred the country’s listed stocks strongly on Sunday, as investors priced in the latest developments and traders took profit. Some Canadian marijuana firms stand to significantly benefit from the opening of one of the oldest pot research markets.

Two of the biggest Canadian beneficiary firms from the latest development in Israel are Cronos Group(TSX:CRON)(NASDAQ:CRON) and Namaste Technologies(TSX:N), and here’s why.

Piper Jaffray analysts re-rated Canopy Growth (TSX:WEED)(NYSE:CGC) on Friday and raised its stock price target from US$40 to US$60. The company believes the near-term prospects of the legalized marijuana market in North America justify the new valuation.

A 50% rise in the target price from one of the most well-known and prestigious Wall Street investment banks is a big deal. Canopy’s stock popped by as much as 10% on the news. Now, the stock trades at US$48.5, indicating upside of nearly 20%.

Although marijuana stocks delivered a subpar year in 2018, the cannabis movement as a whole didn't disappoint. Our neighbor to the north, Canada, wound up legalizing recreational marijuana, thereby ending nine decades of prohibition and opening the curtain to billions of dollars in added annual sales. More importantly, it signified to the world that cannabis was no longer a taboo topic. Rather, it's a legitimate industry where investors have an opportunity to make money.

Organigram reports 419% surge in first-quarter revenue

There are winners and losers in any industry. You can definitely put Cronos Group (NASDAQ:CRON) and Innovative Industrial Properties (NYSE:IIPR) in the former category within the cannabis industry.

The marijuana industry broke through barriers in 2018 that had previously seemed impossible just a decade earlier.

Following years of promises from Canadian Prime Minister Justin Trudeau, and months of debate in the Senate, Canada became the first industrialized country in the world, and only the second overall behind Uruguay, to legalize recreational marijuana. Rolling out the red carpet for cannabis should lead to billions of dollars in added annual sales, but more importantly legitimizes marijuana as a business model that's here to stay.